Limitations, agreements, and source contact

Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia · Source last updated 2025-06-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

NDaver@mdanderson.org

organization

The University of Texas MD Anderson Cancer Center

phone

713-794-4392

title

Naval Daver MD./Professor

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice